Indian Kanoon - Search engine for Indian Law

 Dr. S. Eswara Reddy, Joint Drug Controller (JDC), India at Head Quarter, CDSCO, New Delhi,  Ms.Guljit Sethi @ Guljit Chaudhri, Director M/s Bioinnovat Research Services Private Limited, Delhi,  Sh.Dinesh Dua, Director, M/s Synergy Network India Private Limited, Delhi,  Sh.L. Praveen, Kumar, Associate Vice President and Head- National Regulatory Affairs (NRA), M/s Biocon Biologics Limited, Bangalore,  Sh.Animesh Kumar, Assistant Drug Inspector (ADI), CDSCO, New Delhi;

 and other unknown officials of CDSCO, New Delhi for the commission of offences under Sections 7, 7A, 8 of the PC Act, 1988 and u/s 120-B, 420, 468 and 471 of IPC to contend that as per the FIR/RC No. 0032022A0037 that accused no.1 Dr. Status report Eswara Reddy, Joint Drug Controller, India, Head Quarter, Central Drugs Standard Control Organisation (CDSCO), New Delhi was dealing with processing of files related to applications for approval of drugs and vaccines by various pharmaceutical companies and in this regard, he received three files of M/s Biocon Biologics Limited, Bangalore including one file related to waiver of Phase-III, Clinical trial of "Insulin Aspart Injection" for processing and approval and a bribe for amount of Rs. 30,000/- was paid by accused Guljit Sethi i.e. the respondent no.2 herein to Animesh Kumar, Assistant Drug Inspector (ADI) i.e. the respondent no.5 for processing the file.

11. As per the submissions made by the CBI, the accused Dr. S Eswara Reddy, in criminal conspiracy with co-accused persons and other unknown officers of CDSCO, manipulated minutes of the meeting of Subject Expert Committee including the aforesaid third file of M/s Biocon Biologics Limited, Bangalore in the SEC meeting on 15.06.2022 which resulted into wrongful gain to M/s Biocon Biologics Limited, Bangalore. The CBI has further submitted that as per the investigation conducted so far, it had been revealed that Guljit Sethi i.e. the respondent no.2 was acting as a conduit on behalf of pharmaceutical companies including aforementioned Pharma companies and had delivered/arranged huge bribe amounts for senior officers of CDSCO on different occasions for processing their respective files favorably. Inter alia, it was submitted by the CBI that the source has revealed that co-accused L. Praveen Kumar, AVP i.e. the respondent no.4 herein of M/s Biocon Biologics Limited, Bangalore had agreed to pay an undue pecuniary advantage of Rs 9,00,000/- (Rupees Nine Lacs) as motive/reward to Dr. S. Eswara Reddy, Joint Drug Controller, CDSCO, New Delhi for processing his file favorably and it was informed that Guljit Sethi i.e. the respondent no.2 directed Dinesh Dua i.e. the respondent no.3 to pay a part of the agreed amount to Dr. S. Eswara Reddy at his residence on 20.06.2022 and that on the basis of the said information, it was decided to lay a trap on 20.06.2022 and during the trap proceedings, Dr. S. Eswara Reddy and Dinesh Dua were caught red-handed with a bribe amount of Rs.4,00,000/- (Rupees Four Lacs).

12. The CBI has further submitted that searches were conducted at the residential premises of accused/ respondent no.1- Dr. S. Eswara Reddy i.e D-II, 235, Vinay Marg, Chanakya Puri, New Delhi, accused/ respondent no.3 Dinesh i.e. at A-103, Narang Colony, Janak Puri, New Delhi, accused/respondent No.2 Guljit Sethi i.e. A-1/17, Safdarjung Enclave, New Delhi, accused/ respondent no.5-Animesh Kumar i.e.J 803, Skytech Mattrot, Sector - 76, Noida, Flat No. 202, Brindeshwar Enclave, Road no. 5, Indira Puri, Patna and accused/ respondent no.4 L. Praveen Kumar i.e.C-403, Hinduja Lake, Front Estate, Cave Temple Road, Hulimavu, Bengaluru. Inter alia, the CBI has submitted that searches were also conducted at the office premises of the aforesaid accused persons and various incriminating articles, documents related to the present case had been seized from the above residential and office premises of the accused persons. It has been submitted by the CBI that pursuant to the trap proceedings, Dr. S. Eswara Reddy, Joint Drug Controller (India), CDSCO, Head Quarter, New Delhi, Dinesh Dua, Director, M/s Synergy Network India Private Limited, Delhi, Guljit Sethi @ Guljit Choudhri, Director M/s Bioinnovat Research Services Private Limited, Delhi were arrested on 20.06.2022 whilst Animesh Kumar, Assistant Drug Inspector (ADI), CDSCO, New Delhi was arrested on 21.06.2022.